J

Jeisys Medical Inc
KOSDAQ:287410

Watchlist Manager
Jeisys Medical Inc
KOSDAQ:287410
Watchlist
Price: 12 900 KRW 0.16% Market Closed
Market Cap: ₩976.4B

Jeisys Medical Inc
Note Receivable

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Jeisys Medical Inc
Note Receivable Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Note Receivable CAGR 3Y CAGR 5Y CAGR 10Y
J
Jeisys Medical Inc
KOSDAQ:287410
Note Receivable
-₩300
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
I
I Sens Inc
KOSDAQ:099190
Note Receivable
₩6.1B
CAGR 3-Years
-6%
CAGR 5-Years
1%
CAGR 10-Years
10%
C
Classys Inc
KOSDAQ:214150
Note Receivable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
W
Won Tech Co Ltd
KOSDAQ:336570
Note Receivable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
V
Viol Co Ltd
KOSDAQ:335890
Note Receivable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
Seers Technology Co Ltd
KOSDAQ:458870
Note Receivable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Jeisys Medical Inc
Glance View

Market Cap
976.4B KRW
Industry
Health Care

Jeisys Medical, Inc. manufactures and develops products used by plastic surgeons, dermatologist, physicians and health professionals. The company is headquartered in Seoul, Seoul. The company went IPO on 2018-05-08. The firm manufactures and sells skin care medical devices such as ULTRAcel Q+, POTENZA, and other products. In addition, the Company also provides consumables such as cartridges and tips.

Intrinsic Value
13 222.17 KRW
Undervaluation 2%
Intrinsic Value
Price
J

See Also

What is Jeisys Medical Inc's Note Receivable?
Note Receivable
-300 KRW

Based on the financial report for Jun 30, 2024, Jeisys Medical Inc's Note Receivable amounts to -300 KRW.

Back to Top